🔎 Trials Near Me

Dachaigh › Melanoma › Indiana

Sgrùdaidhean clionaigeach Melanoma ann an Indiana

Tha 14 sgrùdaidhean airson Melanoma a’ lorg phàirtichean aig làraichean ann an Indiana.

Bailtean ann an Indiana

Teacsa sgrùdaidh oifigeil (Beurla)

Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection

  • Reid Health, Richmond
A’ fastadhSgrùdadh amharcFàilte do shaor-thoilich fhallain
Aoisean 40 gu 75 · Gach gnè · Air ùrachadh 2 Dàmh 2026 · NCT05334069

A Study With Combinations of Anti-LAG-3 and Anti-PD-1 Antibodies in Adult Participants With Advanced or Metastatic Melanoma (Harmony Head-to-Head)

  • Fort Wayne Medical Oncology and Hematology, Fort Wayne
A’ fastadhÌre 3
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 25 Sult 2026 · NCT06246916

A Study to Compare the Administration of Encorafenib + Binimetinib + Nivolumab Versus Ipilimumab + Nivolumab in BRAF-V600 Mutant Melanoma With Brain Metastases

  • Reid Health, Richmond
A’ fastadhÌre 2
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 15 Sult 2026 · NCT04511013

Project: Every Child for Younger Patients With Cancer

  • Riley Hospital for Children, Indianapolis
  • Ascension Saint Vincent Indianapolis Hospital, Indianapolis
A’ fastadhSgrùdadh amharc
Suas gu aois 25 · Gach gnè · Air ùrachadh 25 Lùna 2026 · NCT02402244

Tegavivint for the Treatment of Recurrent or Refractory Solid Tumors, Including Lymphomas and Desmoid Tumors

  • Riley Hospital for Children, Indianapolis
A’ fastadhÌre 1/2
12 Months – 30 Years · Gach gnè · Air ùrachadh 25 Lùna 2026 · NCT04851119

A Phase 1 of CTX-8371 in Patients With Advanced Malignancies

  • Fort Wayne Medical Oncology and Hematology, Fort Wayne
A’ fastadhÌre 1
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 28 Iuch 2026 · NCT06150664

Integrated Cancer Repository for Cancer Research

  • Parkview Research Center, Fort Wayne
A’ fastadhSgrùdadh amharcFàilte do shaor-thoilich fhallain
Aoisean 19 gu 110 · Gach gnè · Air ùrachadh 29 Ògmh 2026 · NCT02012699

A Study of VET3-TGI in Patients With Solid Tumors

  • Community Health Network, Indianapolis
A’ fastadhÌre 1
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 7 Gibl 2026 · NCT06444815

Assessing Benefits and Harms of Cannabis/Cannabinoid Use Among Cancer Patients Treated in Community Oncology Clinics

  • Woodland Cancer Care Center, Michigan City
  • Reid Health, Richmond
A’ fastadhSgrùdadh amharc
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 17 Màrt 2026 · NCT06418204

A Phase 1/2 Clinical Trial to Assess the Safety, Tolerability, Pharmacokinetics and Preliminary Efficacy of HMBD-501 in Patients With HER3-Expressing Solid Tumors

  • Research Site, Indianapolis
A’ fastadhÌre 1/2
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 2 Màrt 2026 · NCT06956690

A Study Assessing KB707 for the Treatment of Locally Advanced or Metastatic Solid Tumors

  • IU Simon Comprehensive Cancer Center, Indianapolis
A’ fastadhÌre 1/2
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 18 Cèit 2025 · NCT05970497

BostonGene and Exigent Genomic INsight Study

  • Fort Wayne Medical Oncology and Hematology, Fort Wayne
A’ fastadhSgrùdadh amharc
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 17 Gearr 2025 · NCT06272864

A Study of GV20-0251 Monotherapy and GV20-0251 in Combination With Pembrolizumab in Participants With Solid Tumor Malignancies

  • Community Health Network, Inc., Indianapolis
A’ fastadhÌre 1/2
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 13 Gearr 2025 · NCT05669430

Melanoma Margins Trial-II: 1cm v 2cm Wide Surgical Excision Margins for AJCC Stage II Primary Cutaneous Melanoma

  • Indiana University - Melvin and Bren Simon Cancer Center, Indianapolis
  • Indiana University Melvin and Bren Simon Comprehensive Cancer Center, Indianapolis
  • Franciscan Health Indianapolis, Indianapolis
A’ fastadh
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 27 Samh 2024 · NCT03860883

Bho ClinicalTrials.gov, dàta air a thogail 6 Dàmh 2026. Bidh gach sgrùdadh a’ suidheachadh a chuidi fhèin; bidh an sgioba sgrùdaidh a’ co-dhùnadh cò as urrainn pàirt a ghabhail.